new medication, BG-12, is showing promise in treating MS patients. The study testing this medication has demonstrated a 50% reduction in relapses and a 70% reduction in brain scarring. These are promising results and the FDA approved BG-12 as a first-line oral treatment for MS earlier this year.
new medication, BG-12, is showing promise in treating MS patients. The study testing this medication has demonstrated a 50% reduction in relapses and a 70% reduction in brain scarring. These are promising results and the FDA approved BG-12 as a first-line oral treatment for MS earlier this year.
Essentials of Pharmacology for Health Professions
7th Edition
ISBN:9781305441620
Author:WOODROW
Publisher:WOODROW
Chapter20: Psychotropic Medications, Alcohol, And Drug Abuse
Section: Chapter Questions
Problem 11CRQ
Related questions
Question
A new medication, BG-12, is showing promise in treating MS patients. The study testing this medication has demonstrated a 50% reduction in relapses and a 70% reduction in brain scarring. These are promising results and the FDA approved BG-12 as a first-line oral treatment for MS earlier this year. Overall, is this a good medication?
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 2 steps
Recommended textbooks for you
Essentials of Pharmacology for Health Professions
Nursing
ISBN:
9781305441620
Author:
WOODROW
Publisher:
Cengage
Human Physiology: From Cells to Systems (MindTap …
Biology
ISBN:
9781285866932
Author:
Lauralee Sherwood
Publisher:
Cengage Learning
Essentials of Pharmacology for Health Professions
Nursing
ISBN:
9781305441620
Author:
WOODROW
Publisher:
Cengage
Human Physiology: From Cells to Systems (MindTap …
Biology
ISBN:
9781285866932
Author:
Lauralee Sherwood
Publisher:
Cengage Learning